Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2017 | 12-2016 | 09-2016 | 06-2016 | 12-2015 | |
| Sales | 4,034,160 | 0 | 0 | 4,036,247 | 0 |
| Cost of Goods | 1,087,812 | 0 | 0 | 1,259,173 | 0 |
| Gross Profit | 2,946,348 | 0 | 0 | 2,777,073 | 0 |
| Operating Expenses | 1,192,385 | 0 | 0 | 1,354,970 | 0 |
| Operating Income | 1,754,775 | 0 | 0 | 1,422,277 | 0 |
| Interest Expense | 89,676 | 0 | 0 | 49,960 | 0 |
| Other Income | 119,079 | 0 | 0 | 19,679 | 0 |
| Pre-tax Income | 1,784,178 | 0 | 0 | 1,391,996 | 0 |
| Income Tax | 479,277 | 0 | 0 | 458,797 | 0 |
| Net Income Continuous | 1,304,901 | 0 | 0 | 933,199 | 0 |
| Minority Interests | 1,800 | 0 | 0 | 7,589 | 0 |
| Net Income | $1,303,101 | $0 | $0 | $925,601 | $0 |
| EPS Basic Total Ops | 0.84 | N/A | N/A | 0.59 | N/A |
| EPS Basic Continuous Ops | 0.84 | N/A | N/A | 0.60 | N/A |
| EPS Diluted Total Ops | 0.84 | N/A | N/A | 0.59 | N/A |
| EPS Diluted Continuous Ops | 0.84 | N/A | N/A | 0.60 | N/A |
| EBITDA(a) | $1,754,775 | $0 | $0 | $1,422,277 | $0 |